EQ 200 / Test E 200 by Dragon Pharma

Dragon Pharma Original Formula

Boldenone Undecylenate + Testosterone Enanthate

EQ/Test E Blend400 mg/ml
Composition EQ 200 + Test E 200
Half-Life ~7–14 days
Ratio 1:1 Test:EQ
Carrier MCT Oil
Total per ml 400 mg
Form Injection, 10ml
Availability: In Stock
$88.00
Quantity
Shipping
Wishlist

EQ/Test E Blend — Boldenone Undecylenate 200mg and Testosterone Enanthate 200mg by Dragon Pharma

The EQ/Test E Blend combines Boldenone Undecylenate at 200mg/ml and Testosterone Enanthate at 200mg/ml in a single 400mg/ml vial — two matched long-ester compounds covering the testosterone base and Boldenone's unique combination of EPO-like red blood cell elevation, appetite stimulation and lean muscle quality. A single twice-weekly injection covers the full cycle stack in one draw.

Also searched as: EQ Test E blend, Boldenone Testosterone blend, EQ 200 Test E 200 Dragon Pharma, Equipoise Testosterone Enanthate stack.

Why EQ+Test Is Different From Deca+Test

EQ+Test and Deca+Test are both classic two-compound mass stacks, but produce meaningfully different results through different mechanisms — a distinction competitor content rarely captures:

Parameter EQ + Test (this product) Deca + Test
Secondary compound Boldenone Undecylenate (modified testosterone) Nandrolone Decanoate (19-nor)
RBC / Haematocrit Significant EPO upregulation — notable RBC increase Mild RBC increase
Appetite effect Strong appetite stimulation — caloric surplus easier to maintain Mild appetite increase
Joint effects Minimal joint support Significant — collagen synthesis, fluid retention in joints
Prolactin risk None — Boldenone is not a 19-nor Significant — 19-nor progesterone activity
Water retention Low — drier gains than Deca Moderate — fuller appearance
Muscle quality Lean, vascular — better muscle definition alongside mass Fuller, softer — more glycogen and water retention
Cycle length required 16–20 weeks minimum — Undecylenate ester needs time 14–16 weeks minimum

Boldenone's EPO Mechanism — The RBC Advantage

Boldenone Undecylenate's effect on red blood cell production is its most distinctive property and the most frequently misexplained in competitor content:

  • Boldenone stimulates the kidneys to produce erythropoietin (EPO) — the hormone that signals the bone marrow to produce red blood cells. This is the same mechanism as altitude training and the same target as EPO doping in endurance sports
  • The result is a genuine increase in haematocrit (the proportion of blood volume occupied by red blood cells) — more red blood cells means more oxygen-carrying capacity per unit of blood
  • Increased oxygen delivery to muscle tissue during training translates to improved aerobic capacity, reduced fatigue and faster recovery between sets — not just the direct anabolic effects of Boldenone itself
  • This RBC elevation is more pronounced with Boldenone than with any other commonly used AAS — including Testosterone which produces only a mild RBC increase through a different pathway
  • The haematocrit increase is dose and duration dependent — the EPO elevation becomes meaningful at doses above 300mg/week and after several weeks of use, which is one reason EQ cycles must run long

The Undecylenate Ester — Why EQ Cycles Must Be Long

Boldenone Undecylenate uses the longest ester of any commonly used injectable AAS:

  • The Undecylenate ester has a half-life of approximately 14 days — longer than Decanoate (~15 days, similar), Enanthate (~7-8 days) and significantly longer than Propionate (~2 days)
  • With a 14-day half-life, Boldenone Undecylenate takes approximately 10-12 weeks (5 half-lives) to reach full steady-state blood levels from the first injection
  • Meaningful steady-state EQ blood levels are not reached until weeks 8-10 at the earliest — a cycle of less than 16 weeks ends before Boldenone has contributed its full effect for more than 4-6 weeks
  • Minimum effective EQ cycle: 16 weeks. Experienced users frequently run 20 weeks to maximise the EPO-driven RBC benefits and the gradual quality muscle accumulation that Boldenone produces
  • PCT timing after this blend: 3-4 weeks after the last injection, governed by the Undecylenate ester (similar to Decanoate)

Effects and Benefits

  • EPO-mediated RBC increase — improved oxygen delivery, training endurance and recovery between sets
  • Significant appetite stimulation — easier caloric surplus maintenance for mass building
  • Lean, vascular muscle quality — drier gains than Deca/Test with better definition
  • No prolactin-related side effects — Boldenone is not a 19-nor compound
  • Testosterone base maintains androgenic environment, libido and hormonal wellbeing
  • Twice-weekly single injection covers both compounds at 400mg/ml

Dosage and Administration

Experience Level Weekly Dose Volume (400mg/ml) Frequency Cycle Length
Intermediate 400–600 mg total (200–300mg each) 1–1.5 ml/week Twice weekly 16–20 weeks
Advanced 600–800 mg total (300–400mg each) 1.5–2 ml/week Twice weekly 16–20 weeks

At 400mg/ml, a 1ml twice-weekly injection delivers 400mg/week total (200mg Testosterone Enanthate + 200mg Boldenone Undecylenate). Note that at 200mg/week Boldenone, the EPO-mediated RBC effects are mild — doses of 300-400mg/week EQ are where the erythropoiesis effect becomes clinically meaningful. Users wanting maximum RBC elevation from the blend should run 1.5ml twice-weekly (600mg/week total — 300mg each).

Side Effects

  • Elevated haematocrit — the RBC increase that provides the performance benefit also thickens blood; haematocrit should be monitored and blood donation or hydration used to manage if haematocrit exceeds 50-52%
  • From Testosterone Enanthate: aromatisation — Arimidex or Aromasin for estrogen management if needed
  • Boldenone also aromatises mildly — less than testosterone but present; combined estrogen load from both compounds warrants AI management at higher doses
  • Androgenic effects from both compounds — acne, hair loss in predisposed individuals
  • Suppression of natural testosterone — Post Cycle Therapy required; PCT starts 3-4 weeks after last injection
  • Very long detection window for Boldenone — metabolites detectable for 4-5+ months after last injection

Building a Cycle Around EQ/Test E Blend

  • This blend is self-contained — Testosterone base and Boldenone are both covered in one vial
  • Dianabol 20 as an oral kickstart for weeks 1-6 while both long esters build to effective levels
  • Arimidex for estrogen management — both compounds aromatise, though combined load is less than equivalent testosterone alone
  • Clomid or Nolvadex for PCT 3-4 weeks after last injection

"The EQ/Test E Blend delivers Boldenone's EPO-mediated red blood cell advantage alongside a testosterone base in a single twice-weekly injection — the combination that produces leaner, more vascular mass gains than Deca/Test while adding the unique training endurance benefit of elevated haematocrit."

Storage and Handling

Store at room temperature, away from direct sunlight and heat. Use sterile technique for every draw.

Please log in to write review.

Boldenone stimulates the kidneys to upregulate erythropoietin (EPO) production — the same hormone that signals bone marrow to produce red blood cells. This is the identical mechanism used by altitude training and EPO doping in endurance sports. The resulting haematocrit increase improves oxygen delivery to muscle tissue, translating to better training endurance, reduced fatigue and faster set-to-set recovery.

The Undecylenate ester has a ~14-day half-life — the longest ester of any commonly used injectable AAS. Reaching full steady-state blood levels takes approximately 10-12 weeks. A 12-week cycle ends just as Boldenone reaches maximum effect — leaving only 2-4 weeks at full therapeutic levels. Running 16-20 weeks allows 6-10 weeks at genuine steady-state, maximising both the EPO-driven RBC benefits and the gradual lean muscle quality that Boldenone produces.

EQ+Test produces EPO-mediated RBC elevation (more oxygen delivery, better training endurance), significant appetite stimulation and leaner, more vascular gains with no prolactin risk. Deca+Test produces better joint support through collagen synthesis, fuller and softer muscle appearance from more water retention, and carries prolactin risk requiring Cabergoline management. Neither is objectively superior — the choice depends on goals: EQ for lean vascularity and endurance; Deca for joint support and fuller mass.

No — Boldenone is structurally a modified testosterone derivative, not a 19-nor compound. Prolactin elevation from anabolic steroids is primarily associated with 19-nor compounds (Nandrolone, Trenbolone) through progesterone receptor activity. Boldenone does not carry this risk, and Cabergoline is not required alongside the EQ/Test E Blend.

Monitor haematocrit (via blood test) every 6-8 weeks during an EQ cycle. If haematocrit exceeds approximately 50-52%, blood becomes significantly more viscous — increasing cardiovascular workload and clot risk. Management options include blood donation (therapeutic phlebotomy), increased hydration and dose reduction. Staying well-hydrated throughout an EQ cycle is important for managing this side effect.

3-4 weeks after the last injection, governed by the Boldenone Undecylenate's ~14-day half-life (similar to Nandrolone Decanoate's ~15-day half-life). Despite Testosterone Enanthate clearing faster (~7-8 day half-life), PCT timing must wait for the Boldenone component to reach sub-suppressive levels — both compounds are suppressing the HPG axis until they have cleared.